Stay updated on NC410 Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NC410 Plus Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T10:52:08.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-20T02:17:23.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    1.0%
    Check dated 2025-01-12T22:54:32.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The study titled 'A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors' has transitioned from 'Recruiting' to 'Active, not recruiting', with a new date set for 2024-12-16.
    Difference
    2%
    Check dated 2024-12-22T07:49:22.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T23:24:22.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T20:28:15.000Z thumbnail image

Stay in the know with updates to NC410 Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.